Company record
Seagen Inc. develops and manufactures biopharmaceutical products, concentrating on antibody therapeutics and oral medicines for a broad spectrum of cancers. The company’s portfolio includes treatments for breast, colorectal and gastric cancers, and it also targets solid‑tumor indications such as ovarian, prostate, bladder, esophageal, endometrial and lung tumors.
This directory record does not yet have a linked material-flow brief.